Trial Summary
What is the purpose of this trial?The purpose of the study is to boost colorectal cancer (CRC) screening rates in an underserved population in Brooklyn through organized, proactive outreach of mailed Fecal Immunochemical Tests (FIT), utilizing evidence-based interventions tailored to the needs of the population.
Eligibility Criteria
This trial is for men and women aged 45-75 who are patients or providers at specific clinics in Brooklyn, NY. They must be due or overdue for colorectal cancer screening and have had a medical visit within the past year. Primary caregivers at these clinics can also participate.Inclusion Criteria
Patients with a medical visit of any type at clinic in the past year
Providers who provide care to CRC screen-eligible patients
Patients receiving medical care at NYULH Flatbush FHC and CHN Crown Heights, East New York, East New York Health Hub, Williamsburg clinic sites
+3 more
Exclusion Criteria
Patients in hospice care
Patients with no address or phone number on file
Providers: No longer employed at an included clinic site
+4 more
Participant Groups
The study aims to increase colorectal cancer screening rates among underserved communities by sending out Fecal Immunochemical Tests (FIT) proactively through mail, with strategies tailored to meet the population's needs.
2Treatment groups
Experimental Treatment
Active Control
Group I: Proactive Screening OutreachExperimental Treatment1 Intervention
Participants assigned to the interventional arm will receive proactive outreach of mailed Fecal Immunochemical Tests (FIT) to screen for colorectal cancer.
Group II: Standard of CareActive Control1 Intervention
Participants assigned to the standard of care group will receive usual care (i.e., opportunistic screening for colorectal cancer).
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
NYU Langone HealthBrooklyn, NY
Community Health Care Network of New YorkBrooklyn, NY
Loading ...
Who Is Running the Clinical Trial?
NYU Langone HealthLead Sponsor